← Rhythm Pharmaceuticals
What podcasts say about Rhythm Pharmaceuticals
Every statement, with the speaker, the exact quote and the moment it was said.
What experts have said about Rhythm Pharmaceuticals
5 statements · 5 positive
Rhythm Pharmaceuticals treats a rare genetic form of obesity.
“they treat a very rare form, a genetic form of obesity”
Open the episode · Nasdaq Ekes Out Gain After Nvidia Earnings; Target, Rhythm Pharma, AMG In FocusListen at 22:01
Rhythm Pharmaceuticals’ drug received approval for an additional indication.
“The drug just got an additional indication approved”
Open the episode · Nasdaq Ekes Out Gain After Nvidia Earnings; Target, Rhythm Pharma, AMG In FocusListen at 22:35
Rhythm Pharmaceuticals has strong revenue growth and fund sponsorship.
“Good revenue growth, good fund sponsorship.”
Open the episode · Nasdaq Ekes Out Gain After Nvidia Earnings; Target, Rhythm Pharma, AMG In FocusListen at 24:16
Rhythm Pharmaceuticals is an institutionally supported, high-quality biotech.
“this one, $119 stock, so I would definitely call it an institutional exceptional quality biotech”
Open the episode · Nasdaq Ekes Out Gain After Nvidia Earnings; Target, Rhythm Pharma, AMG In FocusListen at 24:28
Rhythm Pharmaceuticals is worth watching based on its technical setup.
“good name to watch and like the technicals here quite a bit”
Open the episode · Nasdaq Ekes Out Gain After Nvidia Earnings; Target, Rhythm Pharma, AMG In FocusListen at 24:40
Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.